Global Serological Pipettes Market Size, Share, Trends, COVID-19 Impact & Growth Forecast Report – Segmented By Product (1-2 ml, 5 ml, 10 ml, 25 ml, Other (50 ml, etc.)), Material, Application, End-User and Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Analysis from 2025 to 2033
The global serological pipettes market size was valued at USD 223.6 million in 2024 and is estimated to reach USD 347.21 million by 2033 from USD 235.06 million in 2025, registering a CAGR of 5.12% from 2025 to 2033.
Serological pipettes are essential laboratory instruments used for the accurate and controlled transfer of liquid volumes in scientific research, clinical diagnostics, biotechnology, and pharmaceutical applications. These graduated, sterile, and disposable plastic or glass tools enable precise measurements, typically ranging from 1 mL to 50 mL, and are widely used in cell culture work, microbiology, molecular biology, and vaccine development. According to the National Institutes of Health (NIH), global investment in biomedical research has seen steady growth over the past decade, with a notable surge during the pandemic due to increased focus on virology and vaccine development. In addition to academic and government-funded institutions, private biotech and pharmaceutical companies have become major consumers of these consumables.
One of the primary drivers of the serological pipettes market is the rapid expansion of biomedical research and development activities globally. This trend has been further accelerated by the growing emphasis on understanding infectious diseases, cancer biology, genetic disorders, and immunotherapies, all of which require extensive laboratory experimentation involving precise liquid handling techniques. Universities, research institutes, and biopharmaceutical companies rely heavily on serological pipettes for tasks such as cell culture maintenance, media preparation, and reagent transfer. The World Health Organization (WHO) reports that between 2020 and 2023, over 40 new research centers focused on genomics and vaccine development were established in low- and middle-income countries, significantly boosting the demand for laboratory consumables. Additionally, the rise in contract research organizations (CROs) and outsourcing of drug discovery projects has led to an increase in laboratory throughput, which is necessitating large-scale procurement of disposable pipettes to maintain sterility and prevent cross-contamination. Moreover, the ongoing advancements in regenerative medicine and stem cell research have created a consistent need for high-quality, sterile pipettes capable of handling sensitive biological samples.
Another key driver fueling the serological pipettes market is the expansion of clinical diagnostic testing and the modernization of laboratory infrastructure in emerging markets. According to the World Health Organization (WHO), the number of diagnostic laboratories worldwide increased by nearly 25% between 2019 and 2023, with significant growth observed in Asia-Pacific, Latin America, and Sub-Saharan Africa. Serological pipettes play a crucial role in diagnostic workflows, especially in blood testing, microbial culturing, immunoassays, and molecular diagnostics such as PCR. As reported by the Centers for Disease Control and Prevention (CDC), the volume of diagnostic tests performed globally surged following the pandemic, leading to heightened demand for laboratory consumables. Many newly established diagnostic centers now operate under Good Laboratory Practice (GLP) standards, which mandate the use of disposable and sterile pipettes to ensure test accuracy and biosafety. Additionally, the proliferation of point-of-care testing facilities and mobile diagnostic units has further expanded the reach of clinical labs into remote areas, increasing the need for portable and single-use pipetting solutions. Private healthcare providers and hospital networks are also investing in automation and digital pathology, which require standardized liquid handling procedures.
Supply Chain Disruptions and Raw Material Shortages
A major restraint affecting the serological pipettes market is the ongoing challenge of supply chain disruptions and raw material shortages. As per the United Nations Conference on Trade and Development (UNCTAD), global logistics networks experienced unprecedented delays between 2020 and 2023, impacting the production and distribution of laboratory consumables, including plastic-based pipettes. Furthermore, the concentration of raw material suppliers in specific regions increases vulnerability to regional disruptions. For example, China and the United States account for a significant portion of polymer resin production, and any regulatory changes or environmental policies affecting these regions can directly impact global supply chains. These supply-side challenges not only affect the timely availability of serological pipettes but also contribute to cost inflation, forcing laboratories to either delay experiments or seek alternative equipment.
Stringent Regulatory Requirements and Quality Compliance Standards
Another significant barrier in the serological pipettes market is the imposition of stringent regulatory requirements and quality compliance standards. As per the U.S. Food and Drug Administration (FDA), laboratory consumables intended for diagnostic or pharmaceutical use must adhere to rigorous sterilization, traceability, and documentation protocols. According to the European Committee for Standardization (CEN), the implementation of Regulation (EU) 2017/746 on in vitro diagnostic medical devices has further intensified the scrutiny on laboratory consumables, including pipettes used in clinical settings. These regulations mandate comprehensive validation, labeling, and post-market surveillance, adding complexity and cost to product development and commercialization. Moreover, the requirement for gamma irradiation or ethylene oxide sterilization for disposable pipettes introduces additional logistical and environmental considerations.
An emerging opportunity shaping the serological pipettes market is the increasing adoption of automation in life sciences laboratories. According to the Association for Laboratory Automation and Screening (ALAS), the global shift toward high-throughput screening, robotic liquid handling, and automated sample processing has created a growing demand for compatible pipetting solutions. While traditional manual pipettes continue to be widely used, there is a rising preference for standardized, pre-sterilized, and barcode-labeled serological pipettes that integrate seamlessly with automated systems. Additionally, academic and government research institutions are investing in smart lab technologies to enhance reproducibility and data integrity. As per the National Institutes of Health (NIH), many grant-funded projects now prioritize the use of validated and traceable lab consumables, aligning with good scientific practice.
Another significant opportunity driving the serological pipettes market is the global expansion of biosafety and biocontainment facilities, particularly in response to emerging infectious diseases and biodefense initiatives. These advanced containment facilities require strict adherence to biosafety protocols, including the use of disposable and sterile labware to minimize contamination risks. As per the Centers for Disease Control and Prevention (CDC), serological pipettes are considered essential tools in biosafety laboratories due to their ability to handle liquid cultures and viral suspensions safely. The increased construction of biocontainment labs, especially in regions previously lacking such infrastructure, has resulted in a corresponding rise in demand for certified pipettes that meet biosafety level requirements.
One of the most pressing challenges facing the serological pipettes market is the growing environmental concern associated with plastic waste generation. As per the United Nations Environment Programme (UNEP), laboratory plastic waste has become a significant contributor to global microplastic pollution, with disposable pipettes accounting for a substantial share of this waste stream. Most serological pipettes are made from polystyrene or polypropylene, materials that are non-biodegradable and difficult to recycle using conventional methods.
Research institutions and pharmaceutical companies are increasingly under pressure to adopt sustainable practices, prompting a shift toward reusable alternatives or eco-friendly materials. According to the European Environment Agency (EEA), several universities and research centers in Europe have implemented green lab initiatives aimed at reducing single-use plastic consumption. These efforts include the adoption of washable glass pipettes, although they come with limitations related to sterility assurance and labor-intensive cleaning processes.
Additionally, regulatory bodies and funding agencies are beginning to emphasize sustainability criteria in research grants and institutional accreditations. As reported by Nature Sustainability, some journals now encourage researchers to disclose their lab waste footprint as part of publication requirements. These evolving expectations present a challenge for traditional pipette manufacturers, who must balance functionality, sterility, and environmental impact while maintaining product. reliability
Another significant challenge influencing the serological pipettes market is price sensitivity in emerging markets and budget constraints within publicly funded institutions. As per the World Bank, many low- and middle-income countries allocate limited resources to laboratory infrastructure, often prioritizing essential healthcare services over research expenditures. This financial constraint affects procurement decisions, with laboratories frequently opting for lower-cost alternatives or bulk purchases to manage expenses.
According to the Bill & Melinda Gates Foundation, in certain regions of Sub-Saharan Africa and South Asia, laboratories struggle to maintain consistent supplies of basic consumables due to funding limitations and fluctuating exchange rates. Local manufacturers sometimes offer cheaper options; however, concerns regarding quality consistency and sterility assurance persist. Additionally, even in developed markets, tightening research budgets and competitive grant allocations have led institutions to scrutinize operational costs more closely. As reported by the American Society for Microbiology (ASM), some university labs have started implementing shared resource models to optimize consumable usage and reduce waste.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Analysed | By Product, Material, Application, End-User and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Analysed | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
The 5 ml serological pipette segment was the largest and held 28.3% of the serological pepettes market in 2024 due to the widespread use of this volume range across a variety of laboratory applications such as media preparation, cell culture handling, and reagent transfer. According to the National Institutes of Health (NIH), most standard microbiology and tissue culture protocols require moderate volumes between 1 ml and 10 ml, which is making the 5 ml size one of the most frequently used in research and clinical laboratories. As per data from the American Society for Microbiology (ASM), over 60% of surveyed labs reported using 5 ml pipettes daily due to their versatility in both manual and semi-automated workflows. Additionally, many diagnostic assays and vaccine development processes rely heavily on this volume for dilutions and sample aliquoting, further reinforcing demand. Moreover, manufacturers have optimized packaging and sterility assurance specifically for 5 ml pipettes, offering bulk disposable options that align with biosafety and contamination control requirements.
The 25 ml serological pipette segment is projected to expand with a CAGR of 7.3% during the forecast period. According to the Biotechnology Innovation Organization (BIO), the expansion of biomanufacturing facilities especially those involved in monoclonal antibody production and cell-based therapies has driven demand for higher volume pipetting solutions. The 25 ml pipette is particularly useful in batch processing, media transfer, and inoculation procedures where repetitive small-volume transfers would be inefficient. Additionally, academic and government-funded research centers are increasingly utilizing larger volumes for high-throughput screening and microbial biomass cultivation.
The plastic segment was the largest by capturing 40.3% of the serological pipettes market share in 2024. A key factor fueling this segment’s leadership is the widespread adoption of plastic pipettes in high-throughput environments such as pharmaceutical R&D, vaccine manufacturing, and clinical diagnostics. As per the Association for Laboratory Automation and Screening (ALAS), disposable plastic pipettes are compatible with automated liquid handling systems, making them ideal for standardized operations requiring rapid and repeatable results. Moreover, advancements in polymer technology have enhanced the clarity, chemical resistance, and accuracy of plastic pipettes, further reinforcing their reliability. Additionally, governments and regulatory agencies are encouraging the use of sterile, gamma-irradiated plastic pipettes in regulated settings to ensure compliance with Good Laboratory Practice (GLP) and ISO standards.
The polystyrene pipettes segment is projected to expand with a CAGR of 6.3% in the coming years. Polystyrene is widely used in the manufacture of disposable serological pipettes due to its optical clarity, chemical resistance, and ease of sterilization through gamma irradiation or ethylene oxide treatment. Another major driver of this segment’s growth is the expanding use of polystyrene-based pipettes in biosafety laboratories and point-of-care testing centers. As per the Coalition for Epidemic Preparedness Innovations (CEPI), many newly established diagnostic hubs in low-resource settings prefer pre-sterilized, individually wrapped polystyrene pipettes to maintain hygiene and reduce infection risks.
The tissue culture application segment was accounted in holding 35.4% of the serological pipettes market share in 2024. According to the National Institutes of Health (NIH), tissue culture requires precise handling of liquid media, growth factors, and enzymatic dissociation agents, all of which necessitate reliable and sterile pipetting tools. As reported by the American Type Culture Collection (ATCC), over 90% of cell culture laboratories worldwide rely on disposable serological pipettes for routine media changes, subculturing, and cryopreservation procedures. The need for contamination-free environments in stem cell research and cancer biology has further reinforced the demand for high-quality pipettes in this domain.
Additionally, the rise in personalized medicine and gene editing technologies, including CRISPR-based applications, has amplified the importance of maintaining consistent cell lines through accurate fluid handling.
The testing lab segment is swiftly emerging with a CAGR of 8.4% in the next coming years. According to the World Health Organization (WHO), the number of accredited diagnostic laboratories globally has grown by over 25% since 2020, particularly in Asia-Pacific, Latin America, and Sub-Saharan Africa. Many of these labs perform high-volume testing for infectious diseases, food safety, and environmental monitoring, all of which involve frequent use of serological pipettes for sample dilution, inoculation, and reagent mixing. Furthermore, the expansion of point-of-care testing networks and mobile diagnostics has introduced new usage scenarios where disposable pipettes offer advantages in terms of portability and sterility. As per the Global Health Security Index (GHSI), countries are investing in strengthening national laboratory capacities to enhance pandemic preparedness, further boosting demand for precision lab consumables.
The academic and research institutes segment was the dominant segment with 32.3% of the serological pipettes market share in 2024. According to the National Science Foundation (NSF), global investment in basic and applied research has seen steady growth, with over USD 1.5 trillion allocated to scientific research funding in 2022 alone. As reported by the Organisation for Economic Co-operation and Development (OECD), research output from universities and public institutions has surged in recent years, directly correlating with increased demand for laboratory consumables. Additionally, the expansion of postgraduate programs in biological sciences and the establishment of new research parks and innovation hubs have further expanded the user base for serological pipettes. As per the European Commission’s Horizon Europe program, many academic institutions are now integrating advanced lab automation and digital tracking systems by enhancing the need for standardized and traceable pipetting solutions.
The pharmaceutical and biotechnology companies segment is emerging with a CAGR of 9.3% in the next coming years. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the number of biopharmaceutical companies globally has increased by over 20% in the past five years, with significant growth observed in North America, Europe, and Asia-Pacific. Moreover, regulatory mandates emphasizing traceability and sterility in production workflows have led to increased procurement of pre-sterilized, individually packaged pipettes. As per McKinsey & Company, capital investment in biologics and advanced therapies is expected to grow at double-digit rates over the next decade, reinforcing the need for precision liquid handling tools.
North America held 35.4% of the serological pipettes market share in 2024. A key driver of market growth is the expansion of biotechnology and pharmaceutical industries, particularly in states like California, Massachusetts, and New Jersey. Additionally, stringent biosafety regulations and the presence of leading medical device manufacturers contribute to the widespread adoption of disposable pipettes. The increasing integration of automation in laboratory workflows further enhances product demand.
The Europe serological pipettes market is next to North America in holding a significant share due to its robust healthcare system, well-developed research infrastructure, and adherence to quality and safety standards. Countries such as Germany, France, and the United Kingdom serve as key contributors, hosting numerous academic institutions, biotech firms, and diagnostic laboratories.
Another major growth driver is the increasing collaboration between academia and industry players. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), partnerships between research institutions and pharmaceutical companies have accelerated drug discovery and biologics development, further boosting consumable demand. Moreover, the implementation of sustainable lab practices has prompted manufacturers to introduce eco-friendly pipette variants tailored to European markets.
The Asia-Pacific serological pipettes market is having prominent growth opportunities with the rapid expansion driven by growing investments in healthcare, biotechnology, and academic research. According to the Chinese Academy of Sciences, China has significantly scaled up its research funding, with over CNY 3 trillion allocated to science and technology in 2023. Similarly, India’s Department of Biotechnology has launched multiple programs to promote indigenous vaccine production and bio-manufacturing, increasing the demand for precision lab tools. Additionally, the proliferation of diagnostic laboratories and contract research organizations (CROs) has contributed to heightened usage of disposable pipettes. As per the ASEAN Secretariat, several Southeast Asian countries are investing in regional health security frameworks, which include expanding laboratory testing capacities.
The Latin American serological pipettes market is driven by the Brazil and Mexico serving as primary contributors. According to the Pan American Health Organization (PAHO), several Latin American countries have strengthened their diagnostic laboratory networks in response to recent public health challenges. In addition, academic institutions and biotech startups are playing an increasing role in the region’s life sciences landscape. As per the Mexican Association of Biotechnology Enterprises (AMBE), the number of biotech firms in Mexico has risen by over 30% in the past five years, contributing to greater adoption of standardized pipetting tools.
Middle East and Africa serological pipettes market is substantially to grow with notable variations in adoption levels across different sub-regions. Countries such as Saudi Arabia, the United Arab Emirates, and South Africa have relatively strong healthcare and research infrastructures, supporting higher consumption of laboratory consumables.
Thermo Fisher Scientific Inc., Corning Incorporated, Eppendorf AG, Greiner Bio-One International GmbH, Merck KGaA, Sartorius AG, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Tarsons Products Pvt. Ltd. and Sarstedt AG & Co. KG are some of the major companies in the global serological pipettes market.
The competition in the serological pipettes market is marked by the presence of well-established global players who dominate through brand recognition, product reliability, and extensive distribution networks. These companies leverage their long-standing relationships with research institutions, pharmaceutical firms, and diagnostic laboratories to maintain a strong foothold in mature markets such as North America and Europe. However, increasing competition from regional manufacturers offering cost-effective alternatives is reshaping the market landscape in emerging economies where budget constraints influence procurement decisions.
Innovation remains a key differentiator among top-tier suppliers, with ongoing efforts focused on improving pipette accuracy, sterility assurance, and compatibility with automated workflows. Additionally, sustainability has become a critical battleground, as laboratories worldwide adopt greener practices and demand eco-conscious consumables. Companies that successfully integrate environmental considerations into product design while maintaining performance standards are likely to gain a competitive edge
Thermo Fisher Scientific is a global leader in laboratory consumables and equipment, offering a comprehensive range of serological pipettes designed for precision, sterility, and compatibility with automated systems. The company plays a critical role in supplying high-quality pipettes to academic institutions, biotech firms, and pharmaceutical companies worldwide.
Corning Incorporated is renowned for its extensive portfolio of life sciences products, including durable and calibrated serological pipettes used in cell culture and microbiology applications. Corning’s emphasis on quality control and integration with biosafety protocols has made its products a preferred choice among researchers and diagnostic laboratories globally. The company continues to invest in product development and sustainability initiatives to meet evolving market demands.
Sarstedt AG & Co. KG is a leading manufacturer of medical and laboratory consumables, known for its reliable and ergonomically designed serological pipettes. With a focus on sterility assurance and user safety, Sarstedt serves a broad customer base across clinical diagnostics, research, and industrial microbiology. The company's commitment to regulatory compliance and sustainable manufacturing practices further strengthens its reputation in the global serological pipettes market.
One of the primary strategies employed by key players in the serological pipettes market is expanding product portfolios through continuous innovation and customization. Companies are investing in advanced materials, ergonomic designs, and compatibility with automated liquid handling systems to cater to diverse laboratory needs and enhance usability.
Another major approach involves strengthening global distribution networks and forming strategic partnerships with distributors, research institutions, and healthcare providers. By ensuring consistent supply and localized support, manufacturers improve market penetration and customer retention across both developed and emerging regions.
This research report on global serological pipettes market has been segmented and sub-segmented based on the following categories.
By Product
By Material
By Application
By End User
By Region
Frequently Asked Questions
North America and Europe are currently witnessing significant growth in the serological pipettes market due to well-established healthcare infrastructure, high research expenditure, and a large number of research laboratories and academic institutions. Asia-Pacific is also experiencing substantial growth, driven by increasing healthcare spending, a growing number of biotechnology and pharmaceutical companies, and a rising emphasis on disease management and diagnosis.
The global serological pipettes market size is estimated to be worth USD 2.86 billion in 2023 and grow at a CAGR of 14.44% from 2023 to 2028.
The availability of alternative liquid handling devices, high competition among manufacturers, and pricing pressures. Additionally, ensuring compliance with quality standards and regulations is crucial for market players to maintain credibility hinder the market growth.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region